Kidney Donors Suffer Few Ill-Effects From Life-Giving Act
In a landmark study of more than 80,000 live kidney donors from across the United States, Johns Hopkins researchers have found the procedure carries very little medical risk and that, in the long term, people who donate one of their kidneys are likely to live just as long as those who have two healthy ones...

Grandfathered Drug For High Potassium Has No Proven Benefit
For more than half a century, products containing ion exchange resins have been used in patients with dangerously high levels of potassium. However, there is no convincing evidence that these products are actually effective, according to an article appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN)...

Argos Therapeutics Presents Positive Phase 2 Data Of Its Arcelis? Personalized Immunotherapy Platform In Metastatic RCC At ASCO GU Symposium
Argos Therapeutics announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium...

UK's First Pooled Kidney Transplants
The first pooled kidney transplants involving three donor-recipient couples where each recipient received a kidney from a donor they did not know, has successfully taken place in the UK. The transplants took place at the end of 2009 and involved three hospitals, Hammersmith and Guy's and St Thomas' in London, and the Royal Infirmary in Edinburgh...

PROGENSA(R) PCA3 Assay Can Help Guide Repeat Prostate Biopsy Decisions, Data Presented At Leading Medical Meeting Confirm
Gen-Probe's (Nasdaq: GPRO) PROGENSA® PCA3 assay can help determine whether men suspected of having prostate cancer should undergo a repeat biopsy, according to data from the two largest studies to date of the molecular urine test. The studies were presented last week at the American Society of Clinical Oncology's (ASCO) Genitourinary (GU) Cancers Symposium in San Francisco...

Prostate Cancer Therapy Correlates To Specialist Seen
New research published in today's issue of the Archives of Internal Medicine (Vol. 170, No. 5), by an investigator at The Cancer Institute of New Jersey (CINJ) and colleagues at Memorial Sloan-Kettering Cancer Center in New York, shows that the type of specialist that men with localized prostate cancer see can influence the form of therapy they ultimately receive...

Occupational Sunlight Exposure And Kidney Cancer Risk In Men
According to a new study, men employed in occupations with potential exposure to high levels of sunlight have a reduced risk of kidney cancer compared with men who were less likely to be exposed to sunlight at work. The study did not find an association between occupational sunlight exposure and kidney cancer risk in women...

U.S. Representative John B. Larson Visits Connecticut Surgical Group - American Urological Association
U.S. Representative John B. Larson (D-CT) visited the Glastonbury office of Connecticut Surgical Group, a group surgical practice with 14 locations in the greater Hartford area, on Friday, February 26. Urologist Arthur Tarantino, MD, led Rep. Larson on a tour of the facility and explained to the Congressman how the practice serves as a specialty care resource for the community. Dr...

Predictive Biosciences To Present Novel Combination Approach To Molecular Cancer Diagnostics At 2010 Genitourinary Cancers Symposium
Predictive Biosciences announced that the Company will be presenting its novel Multi-Analyte Diagnostic Readout (MADR?) approach to the development of a non-invasive, urinary biomarker based assay for the detection of bladder cancer during the 2010 Genitourinary Cancers Symposium (GU Symposium), being held March 5-7 in San Francisco...

UAB Cancer Center, Urologists Affirm Men Should Take Lead In Deciding Prostate Screening
Men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed, says Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center...

RSS integration by RSSinclude

Alzheimer

تحليل البول : اخطاء شائعه

تحليل البولينا و الكرياتنين

المعلوما ت الطبيه للثقافه الطبيه و لا تغنى عن استشاره الطبيب
تمت مراجعه هذا الجزء بواسطه دكتور اسامه الحصيوى
شروط استخدام الموقع و سياسه الخصوصيه
اخر تحديث بتاريخ 25 يونيو 2008